Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Kh nng thm thu nhanh Vi u im ni bt ca Creapure c hon ton nghin nh, cn vn vi kch thc t l phn t nh hn 20 ln so vi cc Creatine thng thng iu ny gip ch rt nhiu trong qu nhiu hp th ton b lng Creatine np t ngun thc phm b sung, pht huy ti a s hiu qu ca mt sn phm Creatine tinh khit mang ti cho bn
Apoptosis: a review of programmed cell death
Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)
Wang R, Zhang JY, Zhang M, Zhai MG, Di SY, Han QH, et al
US$ 23.46
US$ 24.81
US$ 27.69
US$ 28.82
